Stéphane Chabrier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stéphane Chabrier has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Manoelle Kossorotoff
National center for rare pediatric cerebrovascular diseases (Cervco), APHP University Hospital Necker-Enfants malades, Paris, Inserm U1266, IPNP, Paris, France
8 shared publications - Antoine Giraud
INSERM, U1059 SAINBIOSE, Université Jean Monnet, Saint-Étienne, France
5 shared publications - Mathilde Chevin
Department of Pediatrics, McGill University, Research Institute of the McGill University Health Centre Montreal, QC, Canada
5 shared publications Mickaël Dinomais
Département de Médecine Physique et de Réadaptation Centre Hospitalier Universitaire d'Angers Angers France
5 shared publicationsBéatrice Husson
4 shared publicationsGuillaume Sébire
Child Neurology Division, Department of Paediatrics McGill University QC Canada
4 shared publications
Latest Publications
- Open Access
- 5 October 2023
- Published by Elsevier in Archives de Pédiatrie
- Vol. 30 (8) , 600-606
Long-term developmental condition following neonatal arterial ischemic stroke: A systematic review
- 5 October 2023
- Published by Elsevier in Archives de Pédiatrie
- Vol. 30 (8) , 600-606
Open AccessLong-term developmental condition following neonatal arterial ischemic stroke: A systematic review
- 21 August 2023
- Published by Elsevier in Perfectionnement en Pédiatrie
- Vol. 6 (3) , 188-192
Développement à long terme après accident vasculaire cérébral ischémique artériel néonatal : quelles informations donner aux parents en néonatalogie ?
- 21 August 2023
- Published by Elsevier in Perfectionnement en Pédiatrie
- Vol. 6 (3) , 188-192
Développement à long terme après accident vasculaire cérébral ischémique artériel néonatal : quelles informations donner aux parents en néonatalogie ?
- 4 August 2023
- Published by Elsevier in Perfectionnement en Pédiatrie
- Vol. 6 (3) , 181-187
Quoi de neuf dans la prise en charge de l’accident vasculaire cérébral de l’enfant à la phase aiguë ?
- 4 August 2023
- Published by Elsevier in Perfectionnement en Pédiatrie
- Vol. 6 (3) , 181-187
Quoi de neuf dans la prise en charge de l’accident vasculaire cérébral de l’enfant à la phase aiguë ?
- 14 April 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 8 (82) , eade2860
Encephalitis and poor neuronal death–mediated control of herpes simplex virus in human inherited RIPK3 deficiency
Inborn errors of TLR3-dependent type I IFN immunity in cortical neurons underlie forebrain herpes simplex virus-1 (HSV-1) encephalitis (HSE) due to uncontrolled viral growth and subsequent cell death. We report an otherwise healthy patient with HSE who was compound heterozygous for nonsense (R422*) and frameshift (P493fs9*) RIPK3 variants. Receptor-interacting protein kinase 3 (RIPK3) is a ubiquitous cytoplasmic kinase regulating cell death outcomes, including apoptosis and necroptosis. In vitro, the R422* and P493fs9* RIPK3 proteins impaired cellular apoptosis and necroptosis upon TLR3, TLR4, or TNFR1 stimulation and ZBP1/DAI-mediated necroptotic cell death after HSV-1 infection. The patient’s fibroblasts displayed no detectable RIPK3 expression. After TNFR1 or TLR3 stimulation, the patient’s cells did not undergo apoptosis or necroptosis. After HSV-1 infection, the cells supported excessive viral growth despite normal induction of antiviral IFN-β and IFN-stimulated genes (ISGs). This phenotype was, nevertheless, rescued by application of exogenous type I IFN. The patient’s human pluripotent stem cell (hPSC)–derived cortical neurons displayed impaired cell death and enhanced viral growth after HSV-1 infection, as did isogenic RIPK3-knockout hPSC-derived cortical neurons. Inherited RIPK3 deficiency therefore confers a predisposition to HSE by impairing the cell death–dependent control of HSV-1 in cortical neurons but not their production of or response to type I IFNs.
- 14 April 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 8 (82) , eade2860
Encephalitis and poor neuronal death–mediated control of herpes simplex virus in human inherited RIPK3 deficiency
Inborn errors of TLR3-dependent type I IFN immunity in cortical neurons underlie forebrain herpes simplex virus-1 (HSV-1) encephalitis (HSE) due to uncontrolled viral growth and subsequent cell death. We report an otherwise healthy patient with HSE who was compound heterozygous for nonsense (R422*) and frameshift (P493fs9*) RIPK3 variants. Receptor-interacting protein kinase 3 (RIPK3) is a ubiquitous cytoplasmic kinase regulating cell death outcomes, including apoptosis and necroptosis. In vitro, the R422* and P493fs9* RIPK3 proteins impaired cellular apoptosis and necroptosis upon TLR3, TLR4, or TNFR1 stimulation and ZBP1/DAI-mediated necroptotic cell death after HSV-1 infection. The patient’s fibroblasts displayed no detectable RIPK3 expression. After TNFR1 or TLR3 stimulation, the patient’s cells did not undergo apoptosis or necroptosis. After HSV-1 infection, the cells supported excessive viral growth despite normal induction of antiviral IFN-β and IFN-stimulated genes (ISGs). This phenotype was, nevertheless, rescued by application of exogenous type I IFN. The patient’s human pluripotent stem cell (hPSC)–derived cortical neurons displayed impaired cell death and enhanced viral growth after HSV-1 infection, as did isogenic RIPK3-knockout hPSC-derived cortical neurons. Inherited RIPK3 deficiency therefore confers a predisposition to HSE by impairing the cell death–dependent control of HSV-1 in cortical neurons but not their production of or response to type I IFNs.
- Open Access
Classification Performance of the Ages and Stages Questionnaire: Influence of Maternal Education Level
(1) Background: The Ages and Stages Questionnaire—Third Edition (ASQ-3) is a parental screening questionnaire increasingly being used to evaluate the development of preterm children. We aimed to assess the classification performance of the ASQ-3 in preterm infant follow-up. (2) Methods: In this cross-sectional study, we included 185 children from the SEVE longitudinal cohort born p < 0.01). (4) Conclusions: Regarding the low sensitivity and the impact of a low maternal education level on the classification performance of the ASQ-3, this parental questionnaire should not be used alone to follow the development of preterm children
Open AccessClassification Performance of the Ages and Stages Questionnaire: Influence of Maternal Education Level
(1) Background: The Ages and Stages Questionnaire—Third Edition (ASQ-3) is a parental screening questionnaire increasingly being used to evaluate the development of preterm children. We aimed to assess the classification performance of the ASQ-3 in preterm infant follow-up. (2) Methods: In this cross-sectional study, we included 185 children from the SEVE longitudinal cohort born p < 0.01). (4) Conclusions: Regarding the low sensitivity and the impact of a low maternal education level on the classification performance of the ASQ-3, this parental questionnaire should not be used alone to follow the development of preterm children
- Open Access
- 26 January 2023
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 65 (8) , 1073-1080
Perinatal inflammation exposure and developmental outcomes 7 years after neonatal arterial ischaemic stroke
Aim: To test the association between perinatal inflammation exposure and Full‐Scale IQ (FSIQ) score 7 years after neonatal arterial ischaemic stroke (NAIS).Method: We conducted a cross‐sectional ancillary study nested in a multicentric longitudinal French cohort of infants born at term with NAIS between November 2003 and October 2006. Seventy‐three children were included (45 males, 28 females). The a priori defined primary outcome measure was the FSIQ score assessed with the Wechsler Intelligence Scale for Children, Fourth Edition at 7 years of age.Results: Seventeen (23%) of the included children were exposed to perinatal inflammation. Exposure to perinatal inflammation was independently associated with an increase of FSIQ score (coefficient 13.4, 95% confidence interval 1.3–25.4; p = 0.03). Children exposed to perinatal inflammation had a higher median cerebral volume, a lower median lesion volume, and less extensive lesion distributions compared to non‐exposed children.Interpretation: We propose the existence of two NAIS categories: arteritis‐associated NAIS in children exposed to perinatal inflammation and embolism‐associated NAIS in children non‐exposed to perinatal inflammation. Identifying these two NAIS categories would open the possibility for specific curative strategies: anti‐inflammatory strategy in arteritis‐associated NAIS and recanalization strategy in embolism‐associated NAIS.
- 26 January 2023
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 65 (8) , 1073-1080
Open AccessPerinatal inflammation exposure and developmental outcomes 7 years after neonatal arterial ischaemic stroke
Aim: To test the association between perinatal inflammation exposure and Full‐Scale IQ (FSIQ) score 7 years after neonatal arterial ischaemic stroke (NAIS).Method: We conducted a cross‐sectional ancillary study nested in a multicentric longitudinal French cohort of infants born at term with NAIS between November 2003 and October 2006. Seventy‐three children were included (45 males, 28 females). The a priori defined primary outcome measure was the FSIQ score assessed with the Wechsler Intelligence Scale for Children, Fourth Edition at 7 years of age.Results: Seventeen (23%) of the included children were exposed to perinatal inflammation. Exposure to perinatal inflammation was independently associated with an increase of FSIQ score (coefficient 13.4, 95% confidence interval 1.3–25.4; p = 0.03). Children exposed to perinatal inflammation had a higher median cerebral volume, a lower median lesion volume, and less extensive lesion distributions compared to non‐exposed children.Interpretation: We propose the existence of two NAIS categories: arteritis‐associated NAIS in children exposed to perinatal inflammation and embolism‐associated NAIS in children non‐exposed to perinatal inflammation. Identifying these two NAIS categories would open the possibility for specific curative strategies: anti‐inflammatory strategy in arteritis‐associated NAIS and recanalization strategy in embolism‐associated NAIS.
- 25 January 2023
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 43, 12-15
Post traumatic cerebral sinovenous thrombosis in children: A retrospective and multicenter study
- 25 January 2023
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 43, 12-15
Post traumatic cerebral sinovenous thrombosis in children: A retrospective and multicenter study
- Open Access
- 13 November 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (11) , 2913
Necroptosis Blockade Potentiates the Neuroprotective Effect of Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy
Neonatal encephalopathy (NE) caused by hypoxia-ischemia (HI) affects around 1 per 1000 term newborns and is the leading cause of acquired brain injury and neurodisability. Despite the use of hypothermia (HT) as a standard of care, the incidence of NE and its devastating outcomes remains a major issue. Ongoing research surrounding add-on neuroprotective strategies against NE is important as HT effects are limited, leaving 50% of treated patients with neurological sequelae. Little is known about the interaction between necroptotic blockade and HT in neonatal HI. Using a preclinical Lewis rat model of term human NE induced by HI, we showed a neuroprotective effect of Necrostatin-1 (Nec-1: a compound blocking necroptosis) in combination with HT. The beneficial effect of Nec-1 added to HT against NE injuries was observed at the mechanistic level on both pMLKL and TNF-α, and at the anatomical level on brain volume loss visualized by magnetic resonance imaging (MRI). HT alone showed no effect on activated necroptotic effectors and did not preserve the brain MRI volume. This study opens new avenues of research to understand better the specific cell death mechanisms of brain injuries as well as the potential use of new therapeutics targeting the necroptosis pathway.
- 13 November 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (11) , 2913
Open AccessNecroptosis Blockade Potentiates the Neuroprotective Effect of Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy
Neonatal encephalopathy (NE) caused by hypoxia-ischemia (HI) affects around 1 per 1000 term newborns and is the leading cause of acquired brain injury and neurodisability. Despite the use of hypothermia (HT) as a standard of care, the incidence of NE and its devastating outcomes remains a major issue. Ongoing research surrounding add-on neuroprotective strategies against NE is important as HT effects are limited, leaving 50% of treated patients with neurological sequelae. Little is known about the interaction between necroptotic blockade and HT in neonatal HI. Using a preclinical Lewis rat model of term human NE induced by HI, we showed a neuroprotective effect of Necrostatin-1 (Nec-1: a compound blocking necroptosis) in combination with HT. The beneficial effect of Nec-1 added to HT against NE injuries was observed at the mechanistic level on both pMLKL and TNF-α, and at the anatomical level on brain volume loss visualized by magnetic resonance imaging (MRI). HT alone showed no effect on activated necroptotic effectors and did not preserve the brain MRI volume. This study opens new avenues of research to understand better the specific cell death mechanisms of brain injuries as well as the potential use of new therapeutics targeting the necroptosis pathway.
- Open Access
- 23 June 2021
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 108 (1) , 77-78
Umbilical cord thrombosis and chorioamnionitis in neonatal arterial ischaemic stroke
Women who maintain a normal healthy weight, before, during, and after pregnancy have better outcomes
- 23 June 2021
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 108 (1) , 77-78
Open AccessUmbilical cord thrombosis and chorioamnionitis in neonatal arterial ischaemic stroke
Women who maintain a normal healthy weight, before, during, and after pregnancy have better outcomes
- 1 May 2021
- Published by Elsevier in Bulletin de l'Académie Nationale de Médecine
- Vol. 205 (5) , 490-498
Accident vasculaire cérébral périnatal : nosographie, présentation clinique, pathogénie, facteurs de risque et génétique
- 1 May 2021
- Published by Elsevier in Bulletin de l'Académie Nationale de Médecine
- Vol. 205 (5) , 490-498
Accident vasculaire cérébral périnatal : nosographie, présentation clinique, pathogénie, facteurs de risque et génétique